Angiogenesis in hematologic malignancies

Angiogenesis is defined as the formation of new capillaries from preexisting blood vessels and plays an important role in the progression of solid tumors. Recently a similar relationship has been described in several hematologic malignancies. Expression of the angiogenic peptides vascular endothelia...

Full description

Saved in:
Bibliographic Details
Main Authors: Möhler, Thomas (Author) , Ho, Anthony Dick (Author) , Goldschmidt, Hartmut (Author) , Barlogie, B. (Author)
Format: Article (Journal)
Language:English
Published: [March 2003]
In: Critical reviews in oncology, hematology
Year: 2003, Volume: 45, Issue: 3, Pages: 227-244
ISSN:1879-0461
DOI:10.1016/S1040-8428(02)00135-X
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S1040-8428(02)00135-X
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S104084280200135X
Get full text
Author Notes:T.M. Moehler, A.D. Ho, H. Goldschmidt, B. Barlogie
Description
Summary:Angiogenesis is defined as the formation of new capillaries from preexisting blood vessels and plays an important role in the progression of solid tumors. Recently a similar relationship has been described in several hematologic malignancies. Expression of the angiogenic peptides vascular endothelial growth factor (VEGF) and basic fibroblast growth factor correlates with clinical characteristics in leukemia and non-Hodgkin's-lymphoma and the serum/plasma concentrations serve as predictors of poor prognosis. Increased bone marrow microvessels in multiple myeloma (MM) are correlated with decreased overall survival. Thalidomide which has antiangiogenic effects and direct cytotoxic effects was found to be effective in MM, myelodysplastic syndrome and acute myeloid leukemia (AML). Preliminary data indicate activity of VEGF-tyrosine kinase inhibitors in AML. Clinical research is now aimed at testing antiangiogenic treatment strategies in several hematologic neoplasms as well as identifying the best candidate patients for specific approaches.
Item Description:Gesehen am 10.12.2021
Physical Description:Online Resource
ISSN:1879-0461
DOI:10.1016/S1040-8428(02)00135-X